
Loading, please wait...

Loading, please wait...

Radiologists and pulmonologists increasingly rely on Computed Tomography Angiography (CTA) to manage pulmonary artery pseudoaneurysms. These vascular lesions often cause life-threatening hemoptysis, particularly in clinical settings where tuberculosis is prevalent. Historically, clinicians considered Digital Subtraction Angiography (DSA) the gold standard. However, advanced CTA now provides precise vascular mapping that significantly streamlines the intervention process.
Current research categorizes these lesions into four distinct types based on their blood supply. Type A involves a pure pulmonary artery supply. Type B features a dual supply from both stenosed pulmonary and systemic artery branches. In Type C cases, the supply originates entirely from bronchial or non-bronchial systemic arteries. Finally, Type D represents cases visible on CTA but not immediately apparent on DSA.
This imaging-based classification directly informs the selection of endovascular treatments. For example, clinicians typically treat Type A lesions with pulmonary artery embolization (PAE). Conversely, Type C cases often require bronchial artery embolization (BAE). Type B usually necessitates a combined approach to address both vascular sources. Furthermore, CTA guidance reduces unnecessary vessel cannulation and limits contrast exposure during procedures. Consequently, this targeted strategy enhances both technical and clinical success rates in managing moderate to massive hemoptysis.
Evidence shows that CTA has excellent concordance with DSA for Type A and B lesions. While Type C shows moderate agreement, the initial CTA remains a vital roadmap. Ultimately, utilizing CTA-based mapping ensures a more efficient and safer intervention for patients with complex pulmonary vascular pathology.
CTA provides a pre-procedural roadmap that identifies the specific vascular supply of the pseudoaneurysm. This allows interventionalists to target the correct vessel immediately, reducing procedure time and contrast use.
PAPs are classified as Type A (pulmonary supply), Type B (dual pulmonary and systemic supply), Type C (systemic supply), and Type D (detected only on CTA).
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Kumaraswamy C et al. Pulmonary Artery Pseudoaneurysms: Evaluation of Computed Tomography Angiography-based Vascular Mapping and Classification. J Thorac Imaging. 2026 Feb 23. doi: 10.1097/RTI.0000000000000875. PMID: 41725059.
2. Gorsi U et al. Percutaneous transthoracic embolisation for massive haemoptysis secondary to peripheral pulmonary artery pseudoaneurysms. Eur Radiol. 2021;31(4):2134-2141.
3. Khalil A et al. Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest. 2008;133(1):212-219.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study evaluates CTA-based mapping for pulmonary artery pseudoaneurysms (PAPs), showing how specific classifications guide successful embolization....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today